Table 2 Summary of the longitudinal studies with altered short-term BPV and association with incident chronic kidney disease
From: Short-term blood pressure variability as a potential therapeutic target for kidney disease
Study | Study subject | No. of subjects | Indices of BPV | Type of association | Outcome |
|---|---|---|---|---|---|
An et al. [63] | General population | 102 | Nondipping | Positive | New occurrence of eGFR < 60 mL/min/1.73 m2 or UACR > 30 mg/gCr |
Cho et al. [19] | HTN | 995 | Nondipping or reverse dipping | Positive | New occurrence of eGFR < 60 mL/min/1.73 m2 or UACR > 30 mg/gCr |
Jhee et al. [17] | HTN | 1,173 | ARV | Positive | New occurrence of eGFR < 60 mL/min/1.73 m2, 30% decline in eGFR from baseline, or new occurrence of UPCR > 300 mg/gCr |
McMullan et al. [18] | General population | 603 | Nondipping | Positive | New occurrence of eGFR < 60 mL/min/1.73 m2 or annual decline in eGFR |
Turak et al. [64] | HTN | 622 | MBPS | Positive | New occurrence of eGFR < 60 mL/min/1.73 m2 |